Diagnostic Snapshot
Heart Failure in a Patient With Metastatic Well-Differentiated Neuroendocrine Tumor
Amy Henderson, ANP-BC, AOCNP®, and Salwan Al Mutar, MD
From (1)Parkland Hospital, Dallas, Texas; (2)UT Southwestern Medical Center, Dallas, Texas
Authors’ disclosures of conflicts of interest are found at the end of this article.
Correspondence to: Amy Henderson, ANP-BC, AOCNP, 5220 Harry Hines Boulevard, Dallas, TX 75235. E-mail: amy.henderson@phhs.org
J Adv Pract Oncol 2023;14(4):332–335 |
https://doi.org/10.6004/jadpro.2023.14.4.8 |
© 2023 Harborside™
ABSTRACT
Patients with neuroendocrine malignancy with liver metastases are at risk for carcinoid heart disease which, if left unchecked, can lead to heart failure. This case study demonstrates a clinical situation in which an advanced practitioner performed a thorough workup consisting of lab work and imaging studies, including echocardiogram, cardiac MRI, and dotatate PET/CT, as well as outside record review and comprehensive physical exam. Early detection, intervention, and control of disease are paramount to prevent potentially life-limiting carcinoid heart disease.
For access to the full length article, please
sign in.
